- Cosmos Health increases its Ethereum investment to $1.8 million under its $300 million digital wealth plan.
- CEO Greg Siokas said the company remains committed to accelerating its crypto acquisitions.
- As Cosmos expands in healthcare and digital finance, 200% inventory in 6 months.
Cosmos Health, Inc. (NASDAQ: COSM) strengthens its position in the digital asset with a new $300,000 purchase of Ethereum (ETH), bringing the healthcare group’s total investment in cryptocurrencies to $1.8 million.
The move, announced on Monday, forms part of the company’s broader $300 million digital asset facility aimed at portfolio diversification and long-term growth.
The Chicago-based pharmaceutical manufacturing, distribution and telemedicine company has been increasingly active in the digital assets space in recent months.
Cosmos Health’s stock price has increased nearly 200% in the past six months.
Strategic expansion through digital assets
Cosmos Health’s latest Ethereum acquisition highlights the company’s commitment to integrating digital assets into its broader financial strategy.
“Following our purchases last week, we continued to increase our Ethereum holdings, bringing our total investment in ETH to $1.8 million,” said CEO Greg Siokas.
He further added, “We remain committed to accelerating our acquisition program under our $300 million financing facility,” highlighting the company’s intention to expand its exposure to blockchain-based assets.
The purchase follows a series of crypto investments made under the same program that was first announced earlier this year.
This initiative reflects Cosmos Health’s diversification approach, which balances core healthcare operations with emerging opportunities in digital finance and technology.
Founded in 2009 and incorporated in the State of Nevada, Cosmos Health operates across several major healthcare verticals, including nutritional supplements, branded pharmaceutical products, and medical distribution.
The company operates across Greece and the UK, with major distribution centers in Thessaloniki, Athens and Harlow.
Broader strategic development
Beyond its digital assets, Cosmos Health has aggressively pursued corporate and operational initiatives to expand its global footprint.
The company recently announced the appointment of Theodoros C. Karkantzos to its board of directors.
Karkantzos has more than 15 years of investment and business development experience and will serve on the Nominating and Corporate Governance Committee.
Additionally, Cosmos Health has expanded its Sky Premium Life brand into Kuwait through an exclusive distribution agreement with Diyar United.
Under the agreement, Diyar United will market and distribute the company’s nutritional supplements throughout the Kuwaiti market, further strengthening Cosmos Health’s international presence.
The company also received approval at its recent annual general meeting to increase its authorized shares to 1.5 billion common shares and 300 million preferred shares, with the aim of increasing its financial flexibility.
Diversifying career paths
Cosmos Health’s growing involvement in digital assets, specifically Ethereum, highlights the trend of traditional companies seeking to integrate blockchain and invest in crypto assets as part of their financial diversification strategies.
While the company’s core focus remains healthcare and wellness, its foray into digital assets and partnerships signals a forward-looking approach to technology-driven financial management.
With total investment in Ethereum now at $1.8 million and $300 million in facilities available for further expansion, Cosmos Health appears positioned to continue balancing innovation in both the healthcare and financial markets while aiming for sustainable long-term growth.
